CASI Pharmaceuticals, Inc (DE) Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q4 2022

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
CASI Pharmaceuticals, Inc (DE) quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q4 2022.
  • CASI Pharmaceuticals, Inc (DE) Entity Common Stock, Shares Outstanding for the quarter ending December 31, 2022 was 13.5M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 13.5M Dec 31, 2022 20-F 2023-04-26
Q3 2022 13.6M -126M -90.3% Nov 8, 2022 10-Q 2022-11-14
Q2 2022 13.6M -126M -90.3% Aug 5, 2022 10-Q 2022-08-12
Q1 2022 137M -3.21M -2.3% Mar 18, 2022 10-K 2022-03-28
Q3 2021 140M +15.9M +12.8% Nov 8, 2021 10-Q 2021-11-12
Q2 2021 140M +15.9M +12.8% Aug 10, 2021 10-Q 2021-08-12
Q1 2021 140M +40.8M +41.2% Mar 26, 2021 10-K 2021-03-30
Q3 2020 124M +27.6M +28.6% Nov 6, 2020 10-Q/A 2021-02-10
Q2 2020 124M +28.2M +29.5% Aug 6, 2020 10-Q 2020-08-10
Q1 2020 99M +3.31M +3.46% Mar 11, 2020 10-K 2020-03-16
Q3 2019 96.3M +2.76M +2.95% Nov 6, 2019 10-Q 2019-11-12
Q2 2019 95.7M +9.13M +10.5% Aug 2, 2019 10-Q 2019-08-09
Q1 2019 95.7M +16.1M +20.2% Mar 25, 2019 10-K 2019-03-29
Q3 2018 93.6M +28.5M +43.8% Nov 7, 2018 10-Q 2018-11-14
Q2 2018 86.6M +26.4M +43.8% Aug 8, 2018 10-Q 2018-08-14
Q1 2018 79.6M +19.4M +32.3% Mar 28, 2018 10-K 2018-03-29
Q3 2017 65.1M +4.87M +8.09% Nov 6, 2017 10-Q 2017-11-14
Q2 2017 60.2M +10.7M +21.7% Aug 4, 2017 10-Q 2017-08-14
Q1 2017 60.2M +17.6M +41.4% Mar 22, 2017 10-K 2017-03-31
Q3 2016 60.2M +27.8M +85.5% Nov 7, 2016 10-Q 2016-11-14
Q2 2016 49.5M +17M +52.4% Aug 8, 2016 10-Q 2016-08-15
Q1 2016 42.6M +10.1M +31.2% Mar 18, 2016 10-K 2016-03-28
Q3 2015 32.4M 0 0% Nov 6, 2015 10-Q 2015-11-13
Q2 2015 32.4M +5.41M +20% Aug 7, 2015 10-Q 2015-08-14
Q1 2015 32.4M +5.41M +20% Mar 18, 2015 10-K 2015-03-27
Q3 2014 32.4M +5.41M +20% Nov 7, 2014 10-Q 2014-11-14
Q2 2014 27M +17.4K +0.06% Aug 8, 2014 10-Q 2014-08-14
Q1 2014 27M +17.4K +0.06% Mar 14, 2014 10-K 2014-03-21
Q3 2013 27M +4.54M +20.2% Nov 8, 2013 10-Q 2013-11-14
Q2 2013 27M +4.52M +20.1% Aug 9, 2013 10-Q 2013-08-14
Q1 2013 27M +14.8M +121% Mar 14, 2013 10-K 2013-03-21
Q3 2012 22.5M +10.3M +83.9% Nov 8, 2012 10-Q 2012-11-14
Q2 2012 22.5M +10.3M +83.9% Aug 8, 2012 10-Q 2012-08-14
Q1 2012 12.2M Mar 1, 2012 10-K 2012-03-09
Q3 2011 12.2M Nov 8, 2011 10-Q 2011-11-14
Q2 2011 12.2M Aug 8, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.